HCA Healthcare (NYSE:HCA) Price Target Raised to $409.00

HCA Healthcare (NYSE:HCA) had its target price boosted by stock analysts at Robert W. Baird from $393.00 to $409.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Robert W. Baird‘s price objective points to a potential downside of 9.39% from the company’s previous close.

Other equities analysts have also recently issued research reports about the company. KeyCorp decreased their price objective on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a report on Monday, July 27th. Leerink Partners reaffirmed an “outperform” rating and issued a $492.00 price objective on shares of HCA Healthcare in a report on Friday, September 18th. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Mizuho dropped their target price on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 28th. Finally, UBS Group reduced their price target on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a report on Monday, July 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $469.61.

HCA Healthcare Stock Down 3.0%

Shares of NYSE HCA opened at $451.38 on Wednesday. HCA Healthcare has a 12-month low of $353.99 and a 12-month high of $556.52. The stock’s fifty day simple moving average is $433.68 and its two-hundred day simple moving average is $444.96.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, topping the consensus estimate of $6.65 by $0.57. The firm had revenue of $19.85 billion for the quarter, compared to the consensus estimate of $19.33 billion. The company’s revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the firm earned $6.96 EPS. As a group, equities research analysts anticipate that HCA Healthcare will post 29.51 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. SBI Securities Co. Ltd. raised its holdings in shares of HCA Healthcare by 24.7% during the third quarter. SBI Securities Co. Ltd. now owns 111 shares of the company’s stock valued at $47,000 after acquiring an additional 22 shares during the last quarter. Beacon Capital Management LLC increased its position in shares of HCA Healthcare by 0.7% during the third quarter. Beacon Capital Management LLC now owns 3,631 shares of the company’s stock worth $1,550,000 after purchasing an additional 25 shares in the last quarter. Diversify Advisory Services LLC raised its stake in HCA Healthcare by 3.3% in the 3rd quarter. Diversify Advisory Services LLC now owns 806 shares of the company’s stock valued at $378,000 after purchasing an additional 26 shares during the last quarter. AdvisorNet Financial Inc lifted its holdings in HCA Healthcare by 3.5% in the 3rd quarter. AdvisorNet Financial Inc now owns 994 shares of the company’s stock valued at $468,000 after purchasing an additional 34 shares in the last quarter. Finally, Integrated Advisors Network LLC boosted its stake in HCA Healthcare by 0.6% during the 3rd quarter. Integrated Advisors Network LLC now owns 5,469 shares of the company’s stock worth $2,334,000 after purchasing an additional 35 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA reported third-quarter adjusted earnings of $7.22 per share and revenue of $19.85 billion, exceeding analyst estimates of $6.65 and $19.33 billion, respectively. Revenue increased 3.6% year over year, supported by higher admissions and emergency-room visits. HCA Healthcare beats quarterly profit estimates on demand for medical services
• Positive Sentiment: The company declared a quarterly dividend of $0.78 per share, or $3.12 annually, providing a modest shareholder-return benefit with a stated yield of approximately 0.7%.
• Neutral Sentiment: HCA maintained its existing guidance despite the mixed quarter. Analysts noted that strong admissions and revenue were partially offset by rising costs and lower surgical volumes, including a reported 5.4% decline in ambulatory surgery center volume. HCA Healthcare posts solid Q3 results, maintains guidance
• Negative Sentiment: Management signaled that 2027 earnings could be broadly flat, citing reduced Medicaid payments and reimbursement pressure. That outlook raised concerns about limited profit growth after the current year.
• Negative Sentiment: HCA expects a roughly $400 million impact from the increase in uninsured patients, adding to uncompensated-care expenses and weighing on margins. HCA takes $400M hit from rise in uninsured patients
• Negative Sentiment: The earnings call appears to have amplified investor concerns about reimbursement, payer mix, costs and future growth, overwhelming the quarter’s headline beat. A law firm also announced an investigation on behalf of HCA investors, adding a potential litigation overhang, although no claim has been established. HCA Healthcare shares slide following third-quarter earnings call

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.